Alzheimer's Treatment Centers of America (ATCA) is a medical facility dedicated to treating Alzheimer's disease and related cognitive disorders, including dementia and mild cognitive impairment. Their mission is to enhance the quality of life for patients and their families through personalized care that combines advanced technology with compassionate support.

ATCA utilizes artificial intelligence alongside medical technology to deliver precision medicine tailored to each patient's unique profile. Their treatment protocols are informed by extensive research and include over 50 modalities, such as nutraceuticals, pharmaceuticals, and brain mapping. The center serves patients with various cognitive issues, including those related to Long COVID, and focuses on creating customized treatment plans aimed at halting or reversing cognitive decline.

The center emphasizes a patient-centered experience, providing consultations and ongoing support in a welcoming environment. Founded in 2019 and based in Atlanta, Georgia, ATCA is committed to innovation and effective care in the field of Alzheimer's treatment.